Previous studies have reported that NDN can inhibit the development of colorectal cancer, ovarian cancer, head and neck squamous cell carcinoma, breast cancer, and bladder cancer, and its expression is downregulated in most cancers [16–20]. The gene discussed is NDN; the disease is urinary bladder carcinoma.